Skip to content Skip to sidebar Skip to footer

Low Plasma Gelsolin Fuels Therapy Resistance in ESCC

Introduction Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive forms of esophageal cancer and often presents treatment challenges due to its resistance to chemoradiotherapy (CRT). A recent study titled "Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma" sheds light on an intriguing factor…

Read More